Neonatal ergot poisoning: a persistent iatrogenic illness.

Area of Science:

• Neonatal Medicine
• Pharmacology
• Toxicology

Background:

• Ergot toxicity in newborns is rare but life-threatening, often resulting from medication errors.
• Manifestations include respiratory depression, cyanosis, oliguria, and seizures, with respiratory failure being a common cause of death.
• Limited data exists on effective antidotal therapy, particularly sodium nitroprusside, for neonatal ergotism.

Observation:

• A case of a full-term male infant inadvertently administered methylergonovine instead of naloxone at birth is presented.
• The infant developed respiratory failure requiring intubation several hours after the medication error.
• This highlights the critical need for vigilance in medication administration to neonates.

Findings:

• Sodium nitroprusside infusion rapidly improved peripheral perfusion, ventilation, and renal function in the affected infant.
• The infant was successfully extubated on the third hospital day, indicating the efficacy of the treatment.
• This case underscores the potential life-saving role of sodium nitroprusside in managing neonatal ergot toxicity.

Implications:

• All newborns receiving methylergonovine, even if asymptomatic, require close observation in a neonatal intensive care unit.
• Rapid identification of therapeutic errors and prompt initiation of supportive care, including sodium nitroprusside, are vital.
• This case provides valuable information on the effective management and dosing of sodium nitroprusside for neonatal ergot toxicity.